Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,deferredLongTermLiab,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,capitalSurplus,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,dividendsPaid,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,exchange,currency,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,marketState,market,shortName,exchangeDataDelayedBy,esgPopulated,tradeable,priceHint,regularMarketChangePercent,regularMarketDayRange,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,fax,industry,address2
t0,HYPMY,1541000.0,630915968,,,289505000,1451000,305349000,421955000,752799000,334387000,334387000,-3543000,-49871000,,,,-18128000,1170862000,836475000,418063000,-44882000,-2541000,307633000,305349000,2173159000.0,8615978000.0,9349277000.0,423975000.0,898455000.0,17966706000.0,4478126000.0,229688000.0,3919697000.0,323915000.0,7174577000.0,951454000.0,1773800000.0,1698002000.0,2287607000.0,187884000.0,716416000.0,1030407000.0,1648630000.0,5162951000.0,33589000.0,1871656000.0,5968457000.0,1099344000.0,340649000.0,,42507000,-3497180000,1083417000,300836000,478000,145000,-3045296000,-85118000,151048000,29171000,53931000,-671594000,-180421000,-30690000,-26014000,28433000,-115124000,2875344000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,6.73,1630526089,-0.07999992,6.83,6.83,6.71,2723,6.81,0.0,0.0,0,0,finmb_34669017,Other OTC,Hypera S.A.,BRL,13671,42400,2.4,0.55427253,4.33 - 7.76,-1.0300002,-0.13273199,4.33,7.76,1610582400,1.186,15.651162,0.17415565,PRE,us_market,HYPERA SA,0,False,False,2,-1.1747419,6.71 - 6.83,0.43,14.819,6.7897143,-0.059714317,-0.00879482,6.468913,0.26108694,0.04036025,4471816192,0.45414668,15,America/New_York,EDT,-14400000,0.61,,,7.76,4.33,6.79,6.47,13.67k,42.4k,630.92M,,402.11M,0.00%,0.18%,,,,,,0.22,3.14%,1.19,17.42%,3.95,55.87%,"Jan 13, 2021","Mar 31, 2021",,,"Dec 30, 2020","Mar 30, 2021",30.65%,27.56%,5.09%,15.23%,4.44B,7.04,43.70%,2.63B,1.3B,1.38B,0.43,28.20%,1.7B,2.69,6.75B,72.14,2.26,14.82,1.16B,-1.57B,Value,05676-120,Healthcare,8918,8,9,"Hypera S.A. operates as a pharmaceutical company in Brazil. It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands; dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. The company also provides nutrition, sweeteners, and vitamin supplement products under the Tamarine, Vitasay 50+, BiotÃ´nico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo QuÃ­mica, Torsilax, Neosoro, Doralgina, Flavonid, and Histamin brands. It sells its products through distributors and wholesalers. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in SÃ£o Paulo, Brazil.",SÃ£o Paulo,55 11 3627 4206,SP,7,1622505600,7,Brazil,http://www.hyperapharma.com.br,86400,9,"Av. MagalhAes de Castro, 4800",55 11 3627 4371,Drug Manufacturers—Specialty & Generic,"24th floor, Suite 241 EdifIcio Continental Tower Bairro Cidade Jardim"
t-1,HYPMY,3225120000.0,630915968,,,282753000,1451000,314865000,429381000,699687000,89812000,89812000,180494000,-159991000,,,,-42175000,1134848000,1045036000,435161000,192941000,-10063000,324928000,314865000,1710077000.0,8009095000.0,9240715000.0,382666000.0,1118095000.0,17249810000.0,4478126000.0,392612000.0,3833210000.0,295796000.0,4305518000.0,929379000.0,1754526000.0,4743298000.0,2628626000.0,194716000.0,485796000.0,929657000.0,1546409000.0,7899162000.0,34118000.0,1842456000.0,5051233000.0,920796000.0,715795000.0,,37385000,-233560000,-43372000,-149320000,-41723000,2067000,-187675000,-85118000,195205000,21818000,-21236000,-23205000,-42251000,-83188000,-84810000,44644000,-131925000,5270536000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,6.73,1630526089,-0.07999992,6.83,6.83,6.71,2723,6.81,0.0,0.0,0,0,finmb_34669017,Other OTC,Hypera S.A.,BRL,13671,42400,2.4,0.55427253,4.33 - 7.76,-1.0300002,-0.13273199,4.33,7.76,1610582400,1.186,15.651162,0.17415565,PRE,us_market,HYPERA SA,0,False,False,2,-1.1747419,6.71 - 6.83,0.43,14.819,6.7897143,-0.059714317,-0.00879482,6.468913,0.26108694,0.04036025,4471816192,0.45414668,15,America/New_York,EDT,-14400000,0.61,,,7.76,4.33,6.79,6.47,13.67k,42.4k,630.92M,,402.11M,0.00%,0.18%,,,,,,0.22,3.14%,1.19,17.42%,3.95,55.87%,"Jan 13, 2021","Mar 31, 2021",,,"Dec 30, 2020","Mar 30, 2021",30.65%,27.56%,5.09%,15.23%,4.44B,7.04,43.70%,2.63B,1.3B,1.38B,0.43,28.20%,1.7B,2.69,6.75B,72.14,2.26,14.82,1.16B,-1.57B,Value,05676-120,Healthcare,8918,8,9,"Hypera S.A. operates as a pharmaceutical company in Brazil. It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands; dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. The company also provides nutrition, sweeteners, and vitamin supplement products under the Tamarine, Vitasay 50+, BiotÃ´nico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo QuÃ­mica, Torsilax, Neosoro, Doralgina, Flavonid, and Histamin brands. It sells its products through distributors and wholesalers. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in SÃ£o Paulo, Brazil.",SÃ£o Paulo,55 11 3627 4206,SP,7,1622505600,7,Brazil,http://www.hyperapharma.com.br,86400,9,"Av. MagalhAes de Castro, 4800",55 11 3627 4371,Drug Manufacturers—Specialty & Generic,"24th floor, Suite 241 EdifIcio Continental Tower Bairro Cidade Jardim"
t-2,HYPMY,2994464000.0,630915968,,,327289000,1451000,345629000,395271000,696279000,357781000,357781000,-56773000,-2010000,,,,-22334000,1088497000,730716000,392218000,-30492000,-3994000,349623000,345629000,6301094000.0,7775759000.0,9295558000.0,,816745000.0,17071317000.0,4476060000.0,487585000.0,3703840000.0,345315000.0,,1115658000.0,1276218000.0,4930973000.0,2262247000.0,39460000.0,433847000.0,1115936000.0,1419774000.0,8040839000.0,33392000.0,1730541000.0,5168197000.0,891740000.0,714783000.0,,53400000,-1414723000,720510000,696683000,206637000,28110000,-252928000,-85118000,465112000,29804000,67202000,-23204000,-106773000,-62277000,-28733000,-2624000,-155393000,5778592000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,6.73,1630526089,-0.07999992,6.83,6.83,6.71,2723,6.81,0.0,0.0,0,0,finmb_34669017,Other OTC,Hypera S.A.,BRL,13671,42400,2.4,0.55427253,4.33 - 7.76,-1.0300002,-0.13273199,4.33,7.76,1610582400,1.186,15.651162,0.17415565,PRE,us_market,HYPERA SA,0,False,False,2,-1.1747419,6.71 - 6.83,0.43,14.819,6.7897143,-0.059714317,-0.00879482,6.468913,0.26108694,0.04036025,4471816192,0.45414668,15,America/New_York,EDT,-14400000,0.61,,,7.76,4.33,6.79,6.47,13.67k,42.4k,630.92M,,402.11M,0.00%,0.18%,,,,,,0.22,3.14%,1.19,17.42%,3.95,55.87%,"Jan 13, 2021","Mar 31, 2021",,,"Dec 30, 2020","Mar 30, 2021",30.65%,27.56%,5.09%,15.23%,4.44B,7.04,43.70%,2.63B,1.3B,1.38B,0.43,28.20%,1.7B,2.69,6.75B,72.14,2.26,14.82,1.16B,-1.57B,Value,05676-120,Healthcare,8918,8,9,"Hypera S.A. operates as a pharmaceutical company in Brazil. It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands; dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. The company also provides nutrition, sweeteners, and vitamin supplement products under the Tamarine, Vitasay 50+, BiotÃ´nico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo QuÃ­mica, Torsilax, Neosoro, Doralgina, Flavonid, and Histamin brands. It sells its products through distributors and wholesalers. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in SÃ£o Paulo, Brazil.",SÃ£o Paulo,55 11 3627 4206,SP,7,1622505600,7,Brazil,http://www.hyperapharma.com.br,86400,9,"Av. MagalhAes de Castro, 4800",55 11 3627 4371,Drug Manufacturers—Specialty & Generic,"24th floor, Suite 241 EdifIcio Continental Tower Bairro Cidade Jardim"
t-3,HYPMY,4343965000.0,630915968,,,402362000,1451000,396413000,379558000,690251000,419313000,419313000,-108620000,-54246000,,,,3275000,1050494000,631181000,360243000,-16951000,-2674000,399087000,396413000,378074000.0,6583443000.0,9055204000.0,305190000.0,529509000.0,15638647000.0,4448817000.0,424152000.0,3543707000.0,336644000.0,4333165000.0,-61938000.0,1528389000.0,5183901000.0,2063522000.0,36593000.0,676675000.0,-55971000.0,1288149000.0,8083381000.0,27489000.0,1672936000.0,4163245000.0,802392000.0,555780000.0,1124618000.0,40451000,-119374000,2766708000,2697718000,123884000,340000,2930308000,-85118000,351964000,31146000,26191000,-23922000,-127102000,-226239000,-45408000,69006000,-72367000,6019859000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,6.73,1630526089,-0.07999992,6.83,6.83,6.71,2723,6.81,0.0,0.0,0,0,finmb_34669017,Other OTC,Hypera S.A.,BRL,13671,42400,2.4,0.55427253,4.33 - 7.76,-1.0300002,-0.13273199,4.33,7.76,1610582400,1.186,15.651162,0.17415565,PRE,us_market,HYPERA SA,0,False,False,2,-1.1747419,6.71 - 6.83,0.43,14.819,6.7897143,-0.059714317,-0.00879482,6.468913,0.26108694,0.04036025,4471816192,0.45414668,15,America/New_York,EDT,-14400000,0.61,,,7.76,4.33,6.79,6.47,13.67k,42.4k,630.92M,,402.11M,0.00%,0.18%,,,,,,0.22,3.14%,1.19,17.42%,3.95,55.87%,"Jan 13, 2021","Mar 31, 2021",,,"Dec 30, 2020","Mar 30, 2021",30.65%,27.56%,5.09%,15.23%,4.44B,7.04,43.70%,2.63B,1.3B,1.38B,0.43,28.20%,1.7B,2.69,6.75B,72.14,2.26,14.82,1.16B,-1.57B,Value,05676-120,Healthcare,8918,8,9,"Hypera S.A. operates as a pharmaceutical company in Brazil. It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands; dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. The company also provides nutrition, sweeteners, and vitamin supplement products under the Tamarine, Vitasay 50+, BiotÃ´nico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo QuÃ­mica, Torsilax, Neosoro, Doralgina, Flavonid, and Histamin brands. It sells its products through distributors and wholesalers. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in SÃ£o Paulo, Brazil.",SÃ£o Paulo,55 11 3627 4206,SP,7,1622505600,7,Brazil,http://www.hyperapharma.com.br,86400,9,"Av. MagalhAes de Castro, 4800",55 11 3627 4371,Drug Manufacturers—Specialty & Generic,"24th floor, Suite 241 EdifIcio Continental Tower Bairro Cidade Jardim"
